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5-HT1A 5-hydroxytryptamine (serotonin) receptor 1A 
8-OH-DPAT 8-hydroxy-N,N-dipropyl-2-aminotetralin 
C12E10 Polyoxyethylene (10) lauryl ether 
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GDI  guanine nucleotide dissociation inhibitor 
 GDP guanosine diphosphate 
GEF guanine nucleotide exchange factor 
GMP Guanosine monophosphate 
GPCR G-protein coupled receptor 
GppNHp Guanosine 5′-[β,γ-imido]triphosphate 
G-protein guanine nucleotide binding protein 
GTPγS Guanosine 5′–O-[gamma-thio]triphosphate  
NAD 299 (3R)-3-(dicyclobutylamino)-8-fluoro-3,4-dihydro-2H-1-
benzopyran-5-carboxamide hydrochloride  
NAN-190 1-(2-methoxyphenyl)-4-(4-phthalimidobutyl)piperazine 
RET resonance energy transfer 
Sf9 Spodoptera frugiperda 9 





βγM dimer of β1 and StrepII and CCKACC labeled γ2-subunits 
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1. SIGNAL TRANSDUCTION BY GPCRS  
1.1. GPCRs and transmembrane signaling 
Chemical signal transmission between cells is mainly mediated by trans-
membrane proteins known as G-protein coupled receptors. These receptor 
proteins have extracellular ligand binding domains that recognize various 
signaling molecules such as peptide hormones, neurotransmitters like serotonin, 
acetylcholine – but they can also react to mechanical stimuli or even electro-
magnetic radiation (eg rhodopsin). Ligand binding to the receptor can initiate a 
conformational change in the receptor that alters its interactions with various 
intracellular effectors such as heterotrimeric G-proteins and arrestins. These 
intracellular proteins themselves also play an important role in regulating the 
activity of the receptor, in addition to participating in the transduction of 
receptor-mediated extracellular signals into intracellular responses.  
In addition to their interactions with G-proteins all GPCRs share a common 
structural motif: they have seven transmembrane domains and an extracellular 
N-terminus and an intracellular C-terminus. GPCRs also undergo several post-
translational modifications such as palmitoylation, phosphorylation, 
ubiquitination and glycosylation – which are important for receptor trafficking 
and effector interactions (Escriba et al., 2007). For example, GPCRs can be 
phosphorylated at multiple sites following agonist stimulation. This in turn can 
lead to arresting binding and receptor internalization and desensitization of the 
signaling pathway.  
Between 300 and 800 GPCRs have been estimated to be present in the 
human genome (Bjarnadottir et al., 2006, Sharman et al., 2013), making it one 
of the largest protein families involved in signal transduction. There are 
currently six designated families of GPCRs, which are classified based mainly 
on their extracellular ligand binding domains (Sharman et al., 2013)  
 
Class A (Rhodopsin-like) – tend to bind small ligands deep in their 
binding pockets. 
Class B (Secretin receptor family) – tend to bind large peptides. 
Class C (Metabotropic glutamate/pheromone) – have large “venus 
flytrap” ligand binding domains. 
Adhesion – tend to have exceptionally long extracellular regions that 
facilitate cell and matrix interactions. 
Frizzled – tend to have a cysteine-rich extracellular domain that has been 





Although endogenous GPCR ligands tend to be activating (agonists), other 
types of ligands have been discovered and developed. For example: inverse 
agonists suppress constitutive receptor activity, thus inhibiting the ability of 
some receptors to spontaneously adopt their active conformations in the absence 
of agonists. Additional intermediate binding modes are also possible: (neutral) 
antagonists do not influence the active/inactive receptor equilibria, while partial 
agonists activate the receptor to a lesser extent than full agonists. Recent 
findings have also revealed the existence of biased agonism, where different 
ligands can elicit different downstream responses (Kenakin 2011). In addition to 
the aforementioned orthosteric ligands, receptors may also bind allosteric 
ligands that do not compete with the endogenous ligands and provide yet 
another approach to modulating receptor function. All of these types of ligands 
have found extensive use both in the clinic and the laboratory thanks to the 
comparatively easily accessible (and therefore druggable) extracellular ligand 
binding domains of GPCRs and their importance in the regulation of a vast 
array of physiological processes. Indeed numerous drugs have been developed 
that target GPCRs and a large proportion of the drugs in current clinical use 
(Overington et al., 2006) target these receptors. Despite this many GPCRs still 
have unidentified physiological functions and endogenous ligands (so called 
orphan receptors), so research into the role of GPCRs in various physiological 
processes is still very much ongoing.  
 
 
1.2. 5-HT receptors 
The monoamine 5-hydroxytryptamine (serotonin, 5-HT) in one of the first 
neurotransmitters discovered and it plays multiple roles in the mammalian CNS, 
including regulation of pain, mood, sleep and appetite (Nichols and Nichols 
2008). In addition it has several major roles outside the CNS, eg. regulation of 
the gastrointestinal tract, hemostasis and blood clotting. Serotonin can be found 
in all bilateral animals, but it also often present in plants and fungi, making it 
one of the evolutionarily oldest signaling molecules.  
Seven families of serotonin receptors have been classified in humans and 
many of these families contain multiple receptor subtypes. All of these 
serotonin receptors (except 5-HT3 receptors, which are ligand-gated ion 
channels) are GPCRs. The 5-HT1 family contains five subtypes denoted 5-HT1A, 
5-HT1B, 5-HT1D, 5-HT1E, 5-HT1F and all of them couple to Gi/o proteins, while 
members of the other 5-HT receptor families may couple to Gq/11 or Gs. (Nichols 
and Nichols 2008) 
 In addition to serotonin receptors in the CNS, serotonin transporters also 
play an important role in modulating neurotransmission by terminating the 
signal via reuptake of the neurotransmitter. Many major classes of antidepressants 
target serotonin transporters, as inhibition of serotonin reuptake (which results 
in elevation of synaptic serotonin levels) is commonly thought to enhance mood.  
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 The focus of this study was the 5-HT1A receptor (a 46 kDa protein), which is 
the most widespread of all 5-HT receptors. It was also one of the first cloned 
receptors and one of the most thoroughly studied prototypical GPCRs. Several 
drugs have been designed to target this receptor (Lacivita et al., 2008) and 
activation by selective agonist (buspirone, tandospirone) has been found to 
relieve anxiety and depression. Some atypical antipsychotics also interact with 
this receptor and may play a role in their efficacy.  
In addition to exploring the role of the 5-HT1A receptor as a drug target, it 
has been implicated in some of the symptoms that result after overexposure to 
manganese, such as anxiety or irritability. It has also been shown that high 
affinity agonist binding to 5-HT1A receptors is increased by Mn
2+ in a tissue 
specific manner, where enhancement of agonist binding is especially pro-
nounced in the hippocampus (Parkel et al., 2009). Mn2+ toxicity is also charac-
terized by accumulation of the metal in the hippocampus, in addition to the 
basal ganglia and the cortex (Aschner 1999, Fitsnakis et al., 2006). It has been 
hypothesized that the tissue specific effects of Mn2+ could be explained by 
differences in G-protein coupling (postsynaptic 5-HT1A receptors in the hippo-
campus have little receptor reserve (Meller et al., 2000), while Gi2 subunits are 
abundant (Aoki et al., 1992)) and investigating this possibility was one of the 




GPCRs like the 5-HT1A receptor couple to heterotrimeric guanine nucleotide 
binding proteins (G-proteins), which are peripheral membrane proteins 
composed of α- (40–45 kDa), β-(~36 kDa), and γ-subunits (7–8 kDa). α- and γ- 
subunits are posttranslationally modified with lipid anchors that tether them to 
the plasma membrane. The β-subunit is also anchored as β- and γ-subunits form 
a tight dimer that does not disassociate under physiological conditions. There 
can be multiple combinations of β- and γ-subunits in these dimers as there are at 
least 6 β-subunit subtypes and at least 12 γ-subunit subtypes (Oldham and 
Hamm 2008). There are also at least 21 α-subunit subtypes (Oldham and Hamm 
2008), which together with various βγ-subunit combinations can give rise to 
over a thousand different G-protein heterotrimers. Splice variants of α-subunits 
add even more possibilities to the list. 
 All α-subunits share similar structural motifs and are composed of a GTPase 
domain and an α-helical domain, with the guanine nucleotide-binding site 
situated between these two. The α-helical domain is believed to be responsible 
for sequestering the guanine nucleotide at the binding site, so is has to move in 
order to enable nucleotide exchange (Cherfils and Chabre 2003). The GTPase 
domain contains two flexible α-helices known as switch I and switch II, which 
change conformations when the α-subunit is activated. 
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1.4. G-protein activation and intracellular signaling 
All heterotrimeric G-proteins bind GDP in their inactive state. When activated 
by a receptor their affinity for GDP is decreased and the nucleotide dissociates, 
followed by the association of GTP to the now active G-protein. Depending on 
the G-protein subtype, activation and GTP binding can be followed by 
dissociation of the heterotrimer into α- and βγ-subunits, which can both go on to 
interact with intracellular effector proteins. Subunit dissociation may, however, 
not be required for effector activation (Robishaw and Berlot 2004). Deactivation 
is accomplished by the intrinsic GTPase activity of the α-subunit, which 
hydrolyzes the nucleotide into GDP and returns the complex to the inactive state.  
The activation and deactivation of G-proteins is also regulated by specialized 
proteins, which can, for example, either accelerate (GEFs) or inhibit (GDIs) GDP 
release or accelerate GTP hydrolysis (GAPs) (Siderovski and Millard 2005). 
Some GDIs may also inhibit heterotrimer reassociation by binding to the α-sub-
unit and thus prolonging βγ-dependent signaling, while some G-protein effectors 
may have GAP activity. GPCRs themselves can also be viewed as GEFs. 
Heterotrimeric G-proteins are classified based on the identity of the α-
subunit and its effectors into several families (Milligan and Kostenis 2006). Gi 
family proteins (involved in inhibition of adenylate cyclase or activation of 
phosphodiesterases) are subdivided into Gi/o, Gt, Ggust and Gz. The Gs family is 
comprised of Gs and Golf, which both activate adenylate cyclase. The Gq family 
is responsible for activation of phospholipase C and finally the G12/13 family of 
α-subunits is involved in the activation of Rho family of small GTP-ases.  
 
1.5. Role of Mg2+ and Mn2+ in G-protein  
mediated signal transmission 
Guanosine nucleotides are normally complexed with divalent cations (usually 
Mg2+) under physiological conditions and these divalent cations also play a 
crucial function in the activation/deactivation cycle of G-proteins: they are 
involved in GTP hydrolysis and nucleotide exchange. Divalent cations are also 
indirectly involved in receptor-G-protein interactions as addition of Mg2+ can 
promote GDP release, which in turn results in a transiently nucleotide-free G-
protein. The latter is required for high affinity agonist binding (a state where the 
receptor is bound to a nucleotide-free G-protein) (Rinken 1996). 
Gi protein α-subunits have two binding sites for divalent cations, one with a 
millimolar and the other with a nanomolar affinity (Malarkey 2008). The 
millimolar binding site is thought to be responsible for GDP/GTP exchange and 
high affinity agonist binding, while the nanomolar binding site is thought to be 
required for GTP hydrolysis. Mn2+ could substitute for Mg2+ in either of these 
binding sites (Freisinger and Sigel 2007) but its effects on high affinity agonist 
binding seem to point to competition at the millimolar binding site, as Mn2+ 
concentrations are required to be in that range for enhancement of high affinity 
agonist binding.  
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2. METHODS FOR THE CHARACTERIZATION  
OF RECEPTORS AND G-PROTEINS  
In order to understand how GPCRs and G-proteins work on a molecular level it 
is generally necessary to be able to observe processes related to their 
functioning, in addition to characterizing them in more static terms such as 
based on their structure. This can be difficult as many of these proteins are 
present at relatively low concentrations (typically in the range of low pmol/mg 
total protein) in native tissues and therefore methods to study them under 
physiologically relevant conditions need to be very sensitive. Specificity can 
also be crucial as often several closely related receptors are expressed in the 
tissue or cell line being studied. Historically these issues were first addressed by 
using radiolabeled ligands (Paton and Rang 1965) that bind to distinct receptor 
populations, while in recent years fluorescent labeling has become even more 
popular. In addition to methods based on the binding of labeled ligands, assays 
may also use functional readouts such as generation of secondary messengers 
(Ca2+, cAMP), activation genetically engineered biosensor constructs or even 
more basic responses such as cell survival or proliferation etc. 
Ligand binding assays may be utilized for several purposes: for example to 
conduct basic research into receptor function, distribution and to discriminate 
between receptor subtypes. Ligand displacement assays also find widespread 
use in the development of novel receptor ligands and they may also even be 
employed to estimate endogenous ligand concentrations (or the presence of 
synthetic ligands) in native tissues.  
 
 
2.1. Radioligand binding assays 
Radioisotopes such as 3H, 125I or 32P are ideal tools for labeling ligands in that 
isotopic replacement does not usually affect ligand binding to their target, 
whereas bulkier labels often need careful optimization to prevent loss of 
affinity. However, radioligand binding assays also have several drawbacks such 
as long read times, the requirement for a filtering step to separate bound and 
free ligand and also health hazards and disposal issues. These assays are also 
difficult to fully automate for HTS (even though homogeneous detection 
schemes such as SPA have been developed (Crane and Shih 2004)) and may 
also be quite expensive. The requirement for a filtration step also complicates 
kinetic analyses, whereas with optical methods ligand binding can often be 
monitored in real time. Fluorescent lables also make possible the observation of 
single-molecule binding events at very short timescales, while radioligands can 
be used as tracers to visualize receptor-releated processes deep inside living 




Radioligand binding assays are also somewhat limited in that they do not 
always discriminate between receptor ligands that cause different functional 
responses, ie agonists and antagonists. As ligands are often developed with the 
goal of generating functional responses, several approaches have been 
developed to overcome this limitation. Binding of the nonhydrolyzable 
nucleotide [35S]GTPγS is one such method (Harrison and Traynor 2003). It is 
also perhaps the most direct and immediate downstream functional response 
that is common to all GPCRs, although nucleotide exhange kinetics depend on 
the G-protein that couples to the GPCR and these slow kinetics may render this 
assay unsuitable for G-proteins that do not belong to the Gi family. Still – G-
protein based readouts are perhaps the most unambiguous methods for 
determining functional responses, as the response may be affected by other 
factors when measured further downstream in the signaling cascade. For 
example, even though a full agonist may activate a G-protein, the α- and βγ 
subunits that are released may have opposing effects on downstream effectors 
and lead to a response that more resembles that of a partial agonist or even an 
antagonist. An alternative G-protein based functional assay is based on the 
GTPase activity of G-proteins: hydrolysis of [32P]GTP releases the radioactive 
γ-phosphate, which is separated from the labeled nucleotide by filtration. As 
mentioned previously, homogeneous detection schemes have also been 
developed for radioligands that enable their use in HTS, but hazardous waste 
and safety issues become even more pronounced in such large-scale screening 
projects. Therefore much attention has recently been paid to the development of 
fluorescent ligands.  
 
 
2.2. Fluorescent ligand binding assays 
The possibilities offered by fluorescent ligands have been recognized for 
decades and their uses have varied from being simple radioligand replacements 
to environment-sensitive probes that offer single-molecule level insight into the 
mechanisms, geometries and kinetics of receptor function and interaction with 
their binding partners. Fluorescent detection methods are also one of the few 
methods that can rival and sometimes even surpass radioassays in their 
sensitivity. As is the case with radioligands, it must also be possible to distin-
guish a bound fluorescent ligand from a free one and also specific binding from 
nonspecific binding. Absolute quantitation may also be a significant issue as the 
fluorescence of a fluorophore can be strongly dependent on its immediate 
molecular environment, its orientation, the specific geometry and optical 
properties of the detection instrument (Sridharan et al., 2014). Even when 
calibrated against a known fluorophore it is difficult to ensure that the fluoro-
phores are placed under identical orientations in identical environments 
(biological samples can be very heterogenous). Whereas for radioligands, 
halflives are fundamental constants that are not affected by the environment, 
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although instrumental and experimental parameters may significantly influence 
the detected signal as well (eg by quenching of counting efficiency). 
One of the reasons behind the increasing popularity of fluorescence-based 
methods is the increased availability of improved fluorophores that are bright, 
photostable and less sensitive to environmental parameters such as pH or the 
presence of a hydrophobic background that can result in significant nonspecific 
binding. Beside the choice of the fluorophore it is also critical to consider how 
they are conjugated to the ligand (often the fluorophore can be even bulkier than 
the ligand being labeled) as improper placement or linker lenght can lead to 
significant loss of affinity or even off-target effects, where the fluorophore itself 
can increase the affinity of the probe for undesired interactions and lead to false 
positive results.  
There are still numerous limitations, such as the sensitivity to quenching 
agents, high background autofluorescence or scattering, to fluorescent detection 
methods. Some of these can be overcome by the use of a fluorophore with a 
long fluorescence lifetime (such as the lanthanides Eu or Tb) since 
autofluorescence, for example, tends to have a relatively short lifetime. Another 
approach to fluorescent detection is based on the nonradiative resonant energy 
transfer principle (RET), where – instead of relying on a single fluorophore – 
two optically active labels (with overlapping emission and excitation spectra) 
are used in tandem (Helms and Volkhard 2008). For example a FRET pair can 
be constructed between a fluorescent ligand and a fluorescently labeled 
receptor. In this case a RET signal becomes apparent only when the two 
fluorophores (or a fluorophore and a quencher) are in close proximity (generally 
less than 10 nm). If they are in close proximity the intensity of the donor signal 
is reduced and the intensity of the acceptor signal is increased and this change 
can be used as a sensitive method for measuring their distance from each other. 
Many different labeling strategies can be used for FRET, both inter- and 
intramolecular, in order to characterize the interaction of a protein with its 
various binding partners. An added advantage of this approach is that while 
labeling with a single environment-sensitive fluorophore often requires the use 
of purified receptor preparations in order to minimize background influence, 
RET methods can use less sensitive labels and still yield information about the 
environment thanks to altered donor-acceptor distances or geometries. This 
means that RET-based methods are generally better suited for studying 
receptors in their natural environment such as live cells (Sekar and Periasamy 
2003).  
RET-based methods are often based on the use of genetically engineered 
fluorescent proteins, which are bulkier than synthetic fluorophores by orders of 
magnitude. This can result in severe steric hindrance if placement of the 
fluorescent proteins are not carefully optimized for the protein interactions 
being studied, in addition to possibly affecting the localization, stability or even 
expression levels of the protein being labeled. Fluorescent proteins are also 
often less bright and photostable than small molecule fluorophores and they can 
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be subject to proteolytic cleavage. Therefore efforts have been made to engineer 
small-molecule fluorophores that can be used to specifically label proteins via a 
small genetically engineered binding sites. One such method is based on As-
thiol interactions, where target proteins are modified to express multiple 
cysteine residues (often four or more) that bind biarsenical fluorescent ligands 
such as FlAsH (Griffin et al., 2001). Multiple FlAsH-analogues with different 
spectral properties and binding sites have been developed but their utility in 
cell-based assays has been met with limited success as nonspecific binding 
(which can be accompanied by significant changes in their fluorescent proteins) 
of these fairly hydrophobic proteins to cell membranes and endogenous cysteine 
rich proteins complicates the measurements (Stroffekova et al., 2001). It can 
also be difficult to ensure 1:1 stoichiometry of labeling. The environment-
sensitive nature of some FlAsH-analogues, however, can be advantageous as 
the fluorescent label can be sensitive to changes in the conformation of the 
protein (Nakanishi et al., 2004) or the environment to which the protein is 
localized (eg cytoplasmic or membrane-bound).  
 
 
2.3. Fluorescence polarization 
Another approach to detecting binding of fluorescent ligands to their targets is 
based on the principle of fluorescence polarization: small fluorophores rotate 
rapidly in solution and therefore, if excited with linearly polarized light, emit it 
in random directions. Upon binding to a large protein target the rotation time is 
increased and the emitted light is no longer randomly polarized, which can be 
used as an indicator of binding. This method is homogeneous but depends on 
large changes in the populations of bound and free ligands, so fluorescence 
polarization assays need to be conducted in a mode where the concentrations of 
the target and labeled ligand are approximately equal and also close to their 
dissociation constant (Veikšina et al., 2014) This can be difficult for some 
targets that are expressed at low concentrations in native tissues, so methods to 
increase their abundance and/or decrease background have to be employed. 
Therefore much interest has been paid to expressing target proteins in cell lines, 
which can result in much higher expression levels and – depending on the 
expression system – lower background and crosstalk. 
 
 
2.4. Heterologous expression systems 
Multiple types of GPCRs and G-proteins are often expressed in mammalian 
cells, leading to possibilities for crosstalk due do, for example, competition for 
G-protein subunits or receptor heterodimerization (Rives et al., 2009, McGraw 
et al., 2006). These effects can make the investigations into the roles specific 
receptors or G-proteins difficult, even though overexpression strategies or 
treatment with bacterial toxins, use of fusion proteins etc can help to attain 
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selectivity. An alternative to GPCR signaling complex expression in mam-
malian cells is to introduce them into cell lines that have limited possibilities for 
crosstalk. Numerous such expression strategies have been employed with great 
success. 
Bacterial and fungal expression systems were among the first (Bertin et al., 
1992, King et al., 1990). Very high expression levels (important for structural 
studies, for example) can be attained at relatively low costs, but these single-
celled organisms are often unable to correctly fold and posttranslationally 
modify mammalian proteins. This can significantly alter the functional pro-
perties of the proteins. Therefore multiple strains of bacteria and fungi have 
been created that express mammalian protein processing components, which 
can result in fully functional protein expression. Still, careful control experi-
ments are needed to determine if the proteins are expressed and modified 
correctly and this can be very challenging if the protein being expressed is 
difficult to purify from (or characterize) in its native environment. Therefore, 
when very high expression levels are not critical, it is often more practical to 
use animal cell lines for protein expression.  
One of the simplest protein expression systems using animal cells is based 
on cell lines derived from Spodoptera frugiperda (American fall army worm) 
pupal ovarian tissue that are infected with genetically engineered baculoviruses 
that drive heterologous protein expression using viral promoters (Luckow and 
Summers 1988) Relatively high protein yields are possible (milligrams/liter of 
culture medium), while the posttranslational modification machinery of insect 
cells usually results in the expression of fully active mammalian proteins 
(although glycosylation might be absent or incorrect in some cases) (Sutkowski 
et al., 1994, Taussig et al., 1993, Hepler et al., 1993). Insect cells can also be 
grown in serum free media and in suspension culture without need for CO2 
supplementation (in contrast to most mammalian cell lines), which have made 
them popular for large scale protein expression.  
Another advantage of insect cells in comparison to mammalian cells is their 
lack of G-proteins that couple efficiently to mammalian GPCRs (Butkerait et 
al., 1995). Neither do they express GPCRs that are homologous to mammalian 
receptors or tend form oligomers with mammalian GPCRs, which could alter 
functional responses and ligand binding. Therefore mammalian signaling 
complexes can often be reconstituted in insect cells and studied in relative 
isolation – without the crosstalk that can be common in their native environ-
ment. Although limited coupling to insect G-proteins is possible in many cases: 
such as with the 5-HT1A receptor, which can couple to endogenous inscet Go-
like proteins (Mulheron et al., 1994). Still – coupling is usually significantly 
less efficient and extensive than in mammalian cells and reconstitution of high-
affinity agonist binding in insect cells requires coexpression of mammalian G-




In addition to protein expression in insect cells, baculoviruses themselves 
can be used as a source of proteins for binding and even functional assays: 
budded baculoviruses envelope themselves with their host cell plasma 
membrane (Loisel et al., 1997, Saitoh et al., 2006). Using budded viruses also 
ensures that only fully formed and membrane-bound proteins are present in the 
assay, while simultaneously enriching these components in comparison to Sf9 
cells. This can result in lower nonspecific binding and autofluorescence, which 
makes many assays based on fluorescent ligands (such as polarization based 
assays) more feasible (Veikšina et al., 2014). The cell-free nature of baculovirus 
preparations can also make the system more stable, while their ability to infect 
only insect cells means minimal safety precautions are needed in comparison to 










The overall aim of the thesis was to find new possibilities for studying  
G-protein mediated biochemical regulatory mechanisms in signal transduction. 
Special attention was paid on guanine nucleotide binding and its modulation by 
5-HT1A receptors and the bivalent cations Mg
2+ and Mn2+.  
 
To achieve these general aims, several particular objectives were proposed: 
 
 compare modulation of nucleotide binding by 5-HT1A receptors and Mg2+ 
and Mn2+ in different brain regions and membranes of Sf9 cells with 
different G-proteins.  
 
 monitor nucleotide binding to G-proteins by measuring changes in the 
binding parameters of fluorescent receptor ligands as they interact with  
5-HT1A-G-protein complexes in baculovirus particles of various 
compositions.  
 
 expand possibilities for monitoring nucleotide binding to G-proteins 
using fluorescence-based approaches. 
 















4. MATERIALS AND METHODS 
4.1. Reagents and cell lines  
Spodoptera frugiperda 9 (Sf9) cells were from Invitrogen Life Technologies or 
from Quattromed AS. Tris, HEPES, NaCl, EDTA, MnCl2, MgCl2 were from 
Applichem GmbH. Guanosine diphosphate (GDP), guanosine monophosphate 
(GMP), guanosine 5'-O-[gamma-thio]triphosphate (GTPγS), Guanosine 5′-[β,γ-
imido]triphosphate (GppNHp), ethanedithiol, tris(2-carboxyethyl)phosphine 
(TCEP), serotonin (5-HT), detergents and desthiobiotin were from Sigma-
Aldrich GbmH. β-mercaptoethanol and digitonin were from Merck KGaA. 
Saponin was from Fisher Scientific. Bodipy-FL-NAN-190 (Catalogue # 
201592) was from CellAura. 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine 
and 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphoethanolamine were from Avanti 
Polar Lipids. Mastoparan, 1-(2-methoxyphenyl)-4-(4-phthalimidobutyl)pipe-
razine (NAN-190), (3R)-3-(dicyclobutylamino)-8-fluoro-3,4-dihydro-2H-1-
benzopyran-5-carboxamide hydrochloride, (NAD-299), (S)-N-tert-butyl-3-(4-
(2-methoxyphenyl)-piperazin-1-yl)-2-phenylpropanamide (WAY-100135), N-
[2-[4-(2-methoxyphenyl)-1-piperazinyl]ethyl]-N-(2-pyridyl)cyclohexanecarbox-
amide (WAY-100635) and (±)-8-hydroxy-N,N-dipropyl-2-aminotetralin (8-OH-
DPAT) were from Tocris Bioscience. AsCl3 was from Reachim. 4′,5′-bis(1,2,3-
dithioarsolan-2-yl)-2′,7′-difluorofluorescein (F2FlAsH) was synthesized 
according to published procedures (Spagnuolo et al., 2006). 4′,5′-bis(1,3,2-
dithioarsolan-2-yl)fluorescein (FlAsH) was from Toronto Research Chemicals. 
G-protein α-subunits (αq, αslong, αsshort, αolf and α13) were from Kerafast Inc. 
Tetracysteine-labeled peptide (FLNCCPGCCMEP) was from Bachem AG. 
Fluorescein was from Lambert Instruments. [3H]WAY-100635 (0.6 – 0.8 nM, 
81 Ci/mmol) was from GE Healthcare Life Sciences. [3H]8-OH-DPAT (0.8 – 
1.2 nM, 106 Ci/mmol) and [35S]-GTPγS) (1250 Ci/mmol) were from 
PerkinElmer Life and Analytical Sciences. OptiPhase HiSafe® 3 scintillation 
cocktail was from PerkinElmer Inc. 
 
 
4.2. Preparation of membrane homogenates  
for radioligand binding studies 
Brain tissue membranes: hippocampal and cortical tissue of Wistar rats was 
dissected and collected as described previously (Tonissaar et al., 2008) by prof. 
J. Harro’s group. Bandelin Sonoplus sonicator (Bandelin electronic GmbH) was 
used to homogenize tissues in 50 mM Tris–HCl buffer (pH 7.4, IB), followed 
by incubation for 30 min at room temperature and centrifugation at 43,000 × g 
(Sorvall RC-5C, DuPont Instruments) for 20 min at 4°C. Pellets were re-sus-
pended in IB and centrifuged for two more times. The final pellet was re-sus-
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pended in the buffer and used for experiments immediately or stored at –80°C 
until use. 
Sf9 cell membranes: Sf9 cells (Quattromed) were grown on the Sf900 
medium at 27°C in suspension. The recombinant baculoviruses for G-protein 
subunits and 5-HT1AR were prepared by prof. Johnny Näsman (Åbo Akademi, 
Finland) as described earlier (Nasman et al., 2001). For expression experiments 
Sf9 cells were infected with viruses coding for 5-HT1A receptors, G- and G-
subunits. Cells were harvested after 48 hours by centrifugation and 
homogenized by sonication, centrifuged and washed as described above for 
hippocampal and cortical membranes. 
 
 
4.3. Expression of G-proteins (with or without  
5-HT1A receptors) in Sf9 cells for experiments with 
budded viruses or purified proteins 
G-protein expressing baculoviruses were prepared as described in (Tõntson et 
al., 2012), 5-HT1A expressing baculoviruses were a gift from Johnny Näsman, 
prepared as described in (Nasman et al., 2001). Sf9 cells (Invitrogen), grown in 
serum-free media, were simultaneously coinfected with 5-HT1A (only for 
experiments with budded baculoviruses) and βγM-subunit expressing 
baculoviruses for control experiments with no heterologously expressed G 
protein α-subunits, or also with baculoviruses that were designed to express 
human G-protein α-subunits (either i1, i2 or i3). Sf9 cells were collected after 
cell viability had dropped down to approximately 50% by sedimenting the cells 
by centrifugation at 2000 × g for 5 min, after which the supernatants were 
centrifuged for 30 min at 40 000 × g (Sigma 3K30, SIGMA Laborzentrifugen 
GmbH) to sediment virus particles. The virus pellets were then resuspended in 
resuspension buffer (20 mM HEPES, pH=8.0, 10 mM NaCl, 1 mM EDTA, 
2 mM β-mercaptoethanol and 2% DMSO) and frozen at –80 °C. Cell 




4.4. Purification of G-proteins  
For protein purification experiments the thawed cell pellets were homogenized 
in ice cold homogenization buffer (HB: 20 mM HEPES, pH = 8, 10 mM NaCl, 
2 mM MgCl2, 1 mM EDTA, 5 µM GDP, 5 mM β-mercaptoethanol) and fresh 
protease inhibitors (diluted according to manufacturer’s recommendations: 
Roche Complete EDTA-free, Roche) by sonication (Bandelin SonoPuls). 
Homogenates were then centrifuged for 30 min at 40 000 × g (Sigma 3K30) and 
the resulting membrane pellets resuspended in solubilization buffer (HB with 
1% Na-cholate, 0.1% C12E10 and 0.5% dodecylsucrose) and shaken for 1 h at 
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4 °C at 250 rpm (ELMI DOS-20S, ELMI Ltd). The solubilized proteins were 
separated by centrifugation for 30 min at 40 000 × g (Sigma 3K30) and purified 
with affinity chromatography using Strep-Tactin Superflow high capacity resin 
(IBA GmbH) in Poly-Prep columns (Bio-Rad). The columns were washed with 
washing buffer (WB: 20 mM HEPES, pH = 8, 10 mM NaCl, 1 mM EDTA, 
0.5% C12E10, 5 mM β-mercaptoethanol and optionally 2 mM MgCl2 and 5 µM 
GDP) and the G-proteins were eluted with elution buffer (WB + 2 mM 
desthiobiotin). Eluates were aliquoted, frozen and kept until use at 80 °C. 
 
 
4.5. Analysis of purified G-proteins and  
quantitation of bound GDP 
Protein fractions were analyzed using SDS–PAGE with 12% acrylamide Tricine 
gels (Schagger 2006). Tetracysteine-tagged proteins were visualized using 
F2FlAsH-staining (Spagnuolo et al., 2006) on a Typhoon Trio fluorescence 
imager, followed by Ag-staining (Fermentas PageSilver). For fluorescent 
labeling 2 µM F2FlAsH was added to SDS–PAGE samples during denaturation 
at 98 °C for 15 min, followed by an overnight incubation at 4 °C. Total purified 
protein was quantified by UV-absorbance at 280 nm (NanoDrop 1000, 
NanoDrop products). The amount of GDP that remained bound to our purified 
protein preparations was determined after heating the preparations for 30 min at 
65 °C to denature the protein and release the nucleotide. The GDP concentration 
was determined by measuring the ability of these preheated solutions to inhibit 
Bodipy-FL-GTPγS binding to purified active G proteins, in comparison to 
dilutions of a standard solution of GDP for calibration. 
 
 
4.6. Radioligand binding experiments 
Suspensions of brain membranes (100 g protein/sample) or Sf9 cell 
membranes (15 µg protein/sample) in 50 mM Tris–HCl buffer (pH 7.4) with 1 
mM MgCl2, MnCl2 or EDTA were incubated with fixed concentrations of one 
of the radioligands – [3H]WAY-100635 or [3H]8-OH-DPAT – with a range of 
concentrations of displacing ligands or guanosine nucleotides. The reaction was 
terminated by rapid filtration through GF/B glass fiber filter (Whatman) and 
three washings with 3 ml ice-cold 20 mM K-phosphate-buffer (pH 7.4) 
containing 100 mM NaCl. Radioactivity content of the filters was measured 
using Beckman LS 1800 scintillation counter after overnight incubation of the 
filters in scintillation cocktail. 
Binding of [35S]GTPS was measured in 50 mM Tris–HCl buffer (pH 7.4) 
with 1 mM DTT and 100 mM NaCl in presence of 1 mM MgCl2 or MnCl2. 30 
g protein/sample of brain membranes or 5 g protein/sample of Sf9 cell 
(5HT1AR + Gi) membranes were incubated with 0.2 nM [
35S]GTPγS and 
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different concentrations of displacing guanosine nucleotides as described in 
(Pulges and Rinken 2008). The reaction was terminated, filtered on GF/B and 
bound radioactivity was measured as described above. 
 
 
4.7. Fluorescence anisotropy measurements 
All fluorescence anisotropy measurements were carried out at 28 °C in 96-well 
half area microtiter plates (Corning Product No.3993, Corning Life Sciences) in 
a Pherastar platereader (BMG LABTECH GmbH) as described in (Veiksina et 
al., 2010). Fluorescence anisotropies were measured using (polarized) excitation 
at 485 nm (20 nm bandwidth) and simultaneous dual (polarized) emission at 
520 nm (20 nm bandwidth), which enabled recording of fluorescence emission 
intensities that are parallel and perpendicular to the plane of excitation light. 
Erythrosin B was used for fluorescence polarization calibration (Thompson et 
al., 2002).  
Experiments with Bodipy-FL-NAN-190: The concentration of Bodipy-FL-
NAN-190 was estimated by measuring absorbance at 508 nm using an 
Ultrospec 7000 (GE Healthcare Bio-Sciences AB) spectrophotometer. Before 
fluorescence anisotropy measurements, frozen baculovirus concentrates were 
rapidly thawed and resuspended by passing them through a 28G needle (10 
passes) before adding them to the assay buffer (20 mM HEPES, pH=7.8, 100 
mM NaCl, 1 mM EDTA, 2 mM MgCl2 or MnCl2, 2 mM β-mercaptoethanol and 
(for permeabilization of baculovirus particles) either 10 μg/ml of freshly 
prepared digitonin or saponin. Unless otherwise specified, 5-HT1A receptor 
concentration was 2.33 nM and Bodipy-FL-NAN-190 concentration was 1.35 
nM in the assays and all reagents, proteins and microtiter plates were kept on 
ice prior to the initiation of the measurements.   
Experiments with Bodipy-FL-GTPγS: When Bodipy-FL-GTPγS was used as 
reporter ligand for the determination of nucleotide binding (McEwen et al., 
2001), association and dissociation kinetics were measured using GDP-depleted 
G-proteins (1.5 µM stock solution) that were preincubated with or without 
0.5 µM GDP for 2 h on ice (no added divalent cations during the preincubation) 
prior to the measurement. The baseline fluorescence anisotropy of the reporter 
Bodipy-FL-GTPγS (10 nM) was measured in 20 mM HEPES, pH = 7.8, 10 mM 
NaCl, 1 mM EDTA, 5 mM β-mercaptoethanol, 0.1% C12E10 and either 2 mM 
MgCl2 or MnCl2 (FA buffer) for 30 min. The reactions were initiated by 
addition of the protein samples that had been preincubated on ice (final  
G-protein concentration 60 nM). After monitoring the association reaction for 
60 min, the dissociation of Bodipy-FL-GTPγS was initiated by addition of 100 
µM GTPγS or 100 µM GDP. The apparent affinities of GDP and GTPγS were 
determined by their abilities to displace Bodipy-FL-GTPγS binding. The wells 
were loaded with 100 µl of G-protein (30 nM) in FA buffer along with various 
concentrations of unlabeled nucleotides and mastoparan (10 µM) and incubated 
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for 1 h on ice. Then 5 nM (final concentration) Bodipy-FL-GTPγS was added 
and the reaction was monitored for 120 min. In experiments using mastoparan, 
an activator of G-proteins (Higashijima et al., 1988), each well also contained 
1.4 µg of a mixture of 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine and  
1-palmitoyl-2-oleoyl-sn-glycero-3-phosphoethanolamine liposomes to enhance 
activation by mastoparan (Higashijima et al., 1990). The liposomes were 
prepared by sonication (Bandelin Sonopuls) for five cycles of 10 s and 
overnight shaking at 250 rpm (ELMI DOS-20S) at 4 °C and were used within a 
week of preparation. 
Experiments with F2FlAsH: The apparent affinities of GDP, GMP, GTPγS 
and GppNHp were determined by their abilities to modulate F2FlAsH 
fluorescence anisotropy in the presence of αβγM heterotrimers. For experiments 
with nucleotide-depleted αi-heterotrimers, 5 nM F2FlAsH was used to label 
approximately 40 nM G-proteins and nucleotide affinities were determined at 
2h from the start of the experiment. For experiments with αq, αslong, αsshort, αolf 
and α13, 12.5 nM α-subunits were preincubated on ice with 15 nM βγM for 
60 min, to allow the subunits to associate, before addition of 15 nM F2FlAsH 
and nucleotides. Nucleotide affinities for αslong+βγM, αsshort+βγM, αq+βγM and 
αolf+βγM were determined at 6h from the start of the experiment and for 
α13+βγM at 14h. All measurements (unless specified otherwise) were made in 
20 mM HEPES buffer, pH=7.8, with 1 mM EDTA, 2 mM MgCl2, 10 mM NaCl, 
2 mM β-mercaptoethanol, 1 mM TCEP and 0.1% C12E10. All reagents, 
proteins and microtiter plates were kept on ice prior to the initiation of the 
measurements. In experiments where F2FlAsH and G-proteins were subjected to 
heat denaturation, microtiter plates that had been measured in the platereader for 
6 h were sealed with AbsorbMax adhesive film (Excel Scientific Inc) and 
heated at 70 °C for 1h in an Eppendorf Thermomixer Comfort (Eppendorf AG) 
with shaking at 400 rpm. The plates were then cooled to room temperature, 
unsealed and remeasured in the platereader for an additional 30 min. Data was 
then collected at 30 min from the start of the measurement. 
  
 
4.8. Spectrophotometric measurements  
of F2FlAsH-complexes 
Fluorescence emission spectra of free F2FlAsH (5 nM) and its complexes with 
G-proteins (12.5 nM αolf with or without 10 µM GTPγS, or just 15 nM βγM 
subunits) were determined using a Perkin-Elmer LS 55 luminescence spectro-
meter (PerkinElmer Inc) with excitation at 480 nm and a 10 nm emission slit 




4.9. Fluorescence lifetime measurements  
of F2FlAsH-complexes  
Ffluorescence lifetimes were determined in the frequency domain by using an 
imaging attachment (LIFA-X, Lambert Instruments) consisting of a signal 
generator, Multi-LED excitation source with a 3 W light emitting diode (477 
nm LED), and an intensified CCD Li2CAM-X with GEN-III GaAs 
photocathode. The CCD was mounted on the side port of an iMIC inverted 
digital fluorescence microscope (Till Photonics GmbH). Multi-LED was fiber 
coupled to the epicondenser of iMIC. The filter cube comprised of a BrightLine 
HC 475/35 nm (Semrock) exciter, a zt 491 rdcxt dichroic (Chroma) and a 
BrightLine HC 525/45 nm (Semrock) emitter. For all samples and references a 
series of images with an exposure time of 150 ms was taken at 11 modulating 
frequencies (from 1–120 MHz, with increasing LED AC from 0.1 until 2.5 V) 
and 12 phase-shifts between LED and image intensifier per every modulating 
frequency. Photons were collected with 4 × UPLSAPO objective (Olympus). 
Measurements were made in two independent experiments using 50 nM 
F2FlAsH in the presence or absence of either 60 nM βγM or αolf and α13 (with 
or without 10 µM GTPγS) or 600 nM of tetracysteine-labeled peptide 
(FLNCCPGCCMEP). F2FlAsH and its complexes were preincubated at 28 °C 
for 6 h before lifetime measurements at room temperature. 
 
 
4.10. Data analysis  
All data were analyzed using nonlinear regression with GraphPad Prism 
(GraphPad Software Inc.). 
Data analysis for radioligand binding experiments: Statistical comparison of 
non-linear regression models were performed by F-test as suggested by Draper 
and Hunter (Draper and Hunter 1967). Statistical significance of differences 
was determined by Student-Newman-Keuls test.  
Data analysis for experiments with Bodipy-FL-NAN-190: Fluorescence 
anisotropy data was blank corrected for each experiment before data was pooled 
and fitted for determination of Kd and receptor concentration as described in 
(Veiksina et al., 2014). Fluorescence anisotropy data for Bodipy-FL-NAN dis-
placement by serotonergic agonists and antagonists was pooled and normalized 
before fitting. Data in Tables 2, 3 and 4 were fitted without preliminary blank 
correction and/or normalization. Apparent potency values (pEC50) were 
calculated using three or four parameter competitive binding equations and are 
presented as mean ± SD.  
Data analysis for experiments with Bodipy-FL-GTPγS: Background 
corrected fluorescence anisotropies were calculated using data from at least two 
representative parallel experiments by subtracting background (no added 
fluorophores) parallel and perpendicular fluorescence intensities from the 
corresponding parallel and perpendicular sample intensities. For estimation of 
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association and dissociation kinetics the baseline anisotropy of free Bodipy-FL-
GTPγS was additionally subtracted from sample anisotropies (to correct for 
volume effects caused by addition of proteins and GTPγS). Apparent affinity 
values (pIC50) were calculated using three parameter competitive binding 
equations and data measured at approximately 60 min from the addition of 
Bodipy-FL-GTPγS. The statistical significance of the effects of Mn2+ and 
mastoparan was evaluated using the F-test. Protein purity was estimated using 
ImageJ 1.43 (National Institute of Health) by analyzing Ag-stained gels.  
Data analysis for experiments with F2FlAsH: Fluorescence anisotropy data 
was baseline (F2FlAsH-G-protein complex with no added nucleotides) corrected 
for each experiment before data was pooled and fitted for determination of 
nucleotide affinities. Kinetic curves were also baseline corrected to show the 
appearance of nucleotide-sensitivity. Apparent affinity values (logEC50) were 
calculated using three parameter competitive binding equations (Y=Bottom + 
[(Top-Bottom)/(1+10^(X-logEC50
))]), where X corresponds to logarithm of molar 














5. RESULTS AND DISCUSSION 
5.1. Radioligand based assays for characterizing  
receptor-G-protein coupling in native tissue  
homogenates and Sf9 cell membranes  
The ability of Mn2+ to stabilize high affinity agonist binding has been known for 
a long time for several receptors. In case of 5-HT1A receptors, the effects of 
Mn2+ depend on the region of the brain, showing enhanced high-affinity agonist 
binding in hippocampal membranes, whereas in cortical and Sf9-cell 
membranes no differences between Mg2+ and Mn2+ have been reported. These 
differences between tissues could be explained by selective receptor-G-protein 
coupling, but the exact mechanisms remain unknown. Therefore our initial 
experiments into 5-HT1A and G-protein coupling started with radioligand 
binding experiments using membrane homogenates from specific rat brain 
regions or Sf9 cells (that expressed 5-HT1A receptors and G-proteins), in order 
to make a detailed comparison of the effects of nucleotides and bivalent cations 
on receptor-G-protein complexes expressed in these tissues and to provide a 
control for developing further model systems with more defined compositions. 
Our results showed that that the agonist 5-HT had superior affinity in 
displacing [3H]WAY-100635 (a neutral antagonist) bound to rat hippocampal 
membranes in the presence of Mn2+, in comparison to Mg2+. A two-site binding 
model was statistically preferred, with the apparent affinities of 5-HT being 1.6 
nM and 230 nM for high- and low- affinity binding sites, respectively. In the 
presence of Mn2+ the proportion of high affinity sites (87%) was significantly 
higher than in the presence of Mg2+ (66%). Addition of 30 µM GTPγS 
diminished almost all of the high affinity binding in the presence of Mg2+ (7%), 
while Mn2+ could retain a substantial amount (31%) of high-affinity binding in 
hippocampal membranes. In cortical membranes the enhancement of agonist 
binding by Mn2+ did not appear. Also, in this tissue preparation 30 M GTPγS 
diminished all high affinity agonist binding sites even in the presence of Mn2+. 
Thus, in hippocampal membranes, but not in cortical membranes, Mn2+ 
generated more high-affinity agonist binding sites than Mg2+ did. 
In preparations of Sf9 cell membranes expressing 5-HT1A receptors and Gi2 
proteins (but not in membranes expressing Gs proteins), the agonist 8-OH-
DPAT displaced [3H]WAY-100635 binding also according to the two-site 
model, having apparent affinities of 1.5 nM and 97 nM for high- and low- 
affinity binding sites, respectively. The proportions of high-affinity binding 
sites were similar in the presence of Mn2+ and Mg2+ and in both cases these 
binding sites were lost in the presence of 30 M GTPγS. However, if 1 M 
GTPγS was used to activate G-proteins, 36% of high-affinity binding was 
retained in Sf9 cell membranes in the presence of Mn2+, in comparison to 49% 
in cortical and 61% in hippocampal preparations. No high affinity binding was 
detected in any of these preparations the presence of Mg2+ when 30 M GTPγS 
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was used. Thus enhanced agonist binding to 5-HT1A receptors in the presence of 
Mn2+ appeared also in other tissue preparations, when different concentrations 
of GTPγS were used for activation of the system. 
In summary, these results revealed Mn2+-dependent differences in the 
GTPγS-sensitivity of high-affinity agonist binding between brain regions. In the 
presence of 30 µM GTPγS high-affinity agonist binding was not detected in 
cortical and Sf9 membranes, but not all receptors were turned into low-affinity 
state in hippocampal membranes. After lowering the concentration of GTPγS to 
1 μM, high-affinity agonist binding appeared in the presence of Mn2+ also in 
cortical and Sf9 membranes, but not in the presence of Mg2+. It shows that in 
different preparations 5-HT1A receptors have no principal differences in 
sensitivity to Mn2+, but the effects of nucleotides and the presence of either 
Mg2+ or Mn2+ seem to have crucial role in this regulation 
Further experiments investigated the influence of nucleotides on high-
affinity agonist binding to 5-HT1A receptors by measuring as the ability of 8-
OH-DPAT to displace binding of [3H]WAY-100635 to hippocampal membra-
nes in presence of varying concentrations of guanosine nucleotides and bivalent 
ions. Here, in the presence of Mn2+, GTPγS inhibited high-affinity agonist 
binding with a pIC50 of 6.3, while in the presence of Mg
2+ the pIC50 was 7.0. 
Similar differences appeared also in the case of GDP, which inhibited high-
affinity agonist binding with pIC50 of 4.4 and 3.3 in the presence of Mg
2+ and 
Mn2+, respectively. In a separate experiment we measured how these ions, in 
combination with nucleotides, influence direct binding of [3H]8-OH-DPAT. 
Here both nucleotides studied were less potent by almost an order of a 
magnitude in inhibiting [3H]8-OH-DPAT binding when Mn2+ was present in 
comparison to experiments with Mg2+ (Table 1). A similar tendency was found 
also in cortical membranes, although the difference was smaller; remaining in 
the range of 0.5 logarithmic units (Table 1). Thus, Mn2+ decreased potencies of 
nucleotides for inhibiting agonist high-affinity binding to 5-HT1A receptors and 
this effect was more clearly revealed in hippocampal preparations. These results 
also suggests that the role of Mn2+ in regulating nucleotide binding (and 
therefore high affinity agonist binding) is mainly realized through the G-
proteins that couple with 5-HT1A receptors in various tissues. Therefore direct 
measurements of how Mg2+ and Mn2+ influence nucleotide binding properties of 
G-proteins were undertaken by measuring nucleotide potencies in displacing 
[35S]GTPγS binding in hippocampal, cortical and Sf9 membranes. In this assay 
the nucleotides were more potent than they were at inhibiting agonist high-
affinity binding and the potency decreasing effect of Mn2+ appeared only for 
GDP, but not for GTPγS, in all preparations studied (Table 1). In comparison to 
modulation of high affinity agonist binding, Mn2+ had only a moderate 
influence on the nucleotide’s properties in inhibiting [35S]GTPγS binding. This 
indicates that the main fraction of G-proteins labeled with [35S]GTPγS in brain 
membranes is not directly connected with 5-HT1A receptors and other 
approaches suitable for characterization of the molecular mechanisms behind 
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the regulation of this receptor system by bivalent cations had to be found, since 
it seemed that efficient coupling of the 5-HT1A receptor and G-proteins was 
necessary to detect specific regulation by Mg2+ and Mn2+. 
 
Table 1. Influence of magnesium and manganese on the potencies of guanosine 
nucleotides (pIC50) to inhibit [
3H]8-OH-DPAT (0.5 nM) and [35S] GTPγS (0.2nM) 
binding to preparations of different brain areas 
Hippocampus Cortex 
GDP  GTPγS GDP  GTPγS 
vs. [3H]8-
OH-DPAT 
Mg2+ 4.0±0.3a 6.5±0.1 3.8±0.4 6.1±0.1 
Mn2+ 3.0±0.1 5.5±0.3 3.3±0.2 5.6±0.3 
vs. 
[35S]GTPγS 
Mg2+ 7.6±0.1 8.9±0.1 8.0±0.1 9.1±0.1 
Mn2+ 7.2±0.1 8.8±0.1 7.4±0.1 9.1±0.1 
a pIC50 values presented are the negative logarithm of concentrations of corresponding nucleotides 
causing 50% of inhibition of 0.5nM [3H]8-OH-DPAT or 0.2nM [35S]GTPγS binding to 
corresponding membrane preparation. 
 
Therefore we decided to continue our studies using budded baculoviruses from 
Sf9 cells, where 5-HT1A receptors could be reconstituted with specific G-protein 
subunits. Budded baculoviruses were chosen as the basis for this model system 
as they represent a concentrated and well-defined source of receptors and are 
therefore especially suited for fluorescence-based assays (Veikšina et al., 2014). 
By investigating the effects of Mn2+ and nucleotides on partial agonist binding 
in this model system, we aimed to selectively address receptor-G-protein 
coupling.   
 
 
5.2. Characterizing receptor-G-protein coupling in budded 
baculovirus particles with fluorescent ligands  
Our experiments using budded baculoviral particles as a model system for 
studying 5-HT1A receptor coupling to G-proteins began with an initial 
characterization of Bodipy-FL-NAN-190, which is a novel 5-HT1A specific 
fluorescent ligand. It is especially interesting for fluorescence anisotropy based 
applications as the fluorophore in conjugated to the ligand using a restrained 
linker, which should result in a large change in anisotropy upon binding to its 
target. Indeed the results showed large specific changes in both fluorescence 
intensity and anisotropy when Bodipy-FL-NAN-190 was added to 5-HT1A 
receptors expressed in baculovirus particles, while there was no significant 
specific anisotropy change when virus particles without 5-HT1A receptors were 
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used. The binding of Bodipy-FL-NAN-190 was rapid: association curves 
quickly reached a plateau and were fitted as a single phase exponential 
functions (although the reaction was not pseudo first order) and resulted in an 
apparent t½ of 44.8 s. Dissociation kinetics were likewise rapid and single 
phase, with an apparent t½ of 244 s. As both association and dissociation 
kinetics were rapid a steady-state analysis of Bodipy-FL-NAN-190 binding 
could be used for estimation of Kd of the ligand, which resulted in a value of 
0.30 nM. This is in agreement with affinity proposed in IUPHAR-DB for NAN-
190 (Newman-Tancredi et al., 1998).  
 
5.2.1 Pharmacological characterization  
of the baculovirus-based model system 
As Bodipy-FL-NAN-190 could be displaced from 5-HT1A receptor expressing 
baculovirus particles using serotonergic ligands, it was used to characterize the 
binding of various such ligands in the presence or absence of GTPγS (and, in 
some cases, to compare the effects of Mg2+ and Mn2+) to further characterize 
this model system.  
Antagonist displacement experiments yielded single-site binding curves with 
the pIC50 values (Table 2) of the studied ligands being close to their previously 
reported vales. Addition of GTPγS had limited effects on ligand binding and did 
not substantially alter the pIC50 values, but it did appear to lower the 
fluorescence anisotropy of Bodipy-FL-NAN-190 in the absence of competing 
ligands. This suggests that Bodipy-FL-NAN-190 binding is agonist-like 
([3H]NAN-190 has also been reported to behave like a partial agonist in binding 
experiments (Rydelek-Fitzgerald et al., 1990), where nucleotides decreased the 
Bmax of [
3H]NAN-190 by over 20%) and that GTPγS decreases high affinity 
Bodipy-FL-NAN-190 binding probably by limiting the amount of nucleotide-
free G-proteins that are able to associate with the 5-HT1A receptor.  
Displacement experiments with 5-HT1A agonists however yielded two-site 
binding curves, with the pIC50 values measured also being close to their 
previously reported values (Table 2) (Newman-Tancredi et al., 2001). The 
effect of GTPγS was again mainly apparent in the absence of significant 
amounts of competing ligands, but here we could additionally study nucleotide 
effects on the relative proportions of high and low affinity binding sites. The 
effects of GTPγS on the proportion of high affinity agonist binding sites were 
small in the absence of coexpressed αi-subunits, indicating limited coupling of 
insect G-proteins to 5-HT1A receptors. When we coinfected our previously 
described 5-HT1A receptor and β1γ2-subunit expressing Sf9 cells with 
baculoviruses encoding αi-subunits, we saw significantly larger nucleotide 
effects on high affinity Bodipy-FL-NAN-190 binding (Table 3). The proportion 
of high affinity binding sites for αi-subunit containing baculovirus particles (in 
the presence of Mg2+, with shared pIC50 values for GTPγS treated and untreated 
datasets) was between 36% and 53% and addition of GTPγS lowered this down 
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to 19–32%, whereas when no mammalian α-subunits were coinfected the 
proportion of high affinity binding sites was 19% in the absence and almost 
unaltered in the presence of GTPγS. This result indicates that all three 
mammalian αi-subunits can couple to 5-HT1A receptors in budded baculovirus 
particles and this can enhance high affinity agonist binding. 
 
Table 2. Apparent potencies of ligands in competition with 1.35 nM Bodipy-FL-NAN-
190 at 5-HT1A receptors in budded baculoviruses 
Ligand 










WAY 100135 7.3±0.1*  7.3±0.1*  
WAY 100635 8.20±0.03*  8.00±0.04*  
NAD-299 8.50±0.03*  8.40±0.04*  

















L values were calculated from displacement curves against 1.35 nM Bodipy-FL-
NAN-190 according two- or one-site binding models. Data are mean ± SD of pooled data of 2 
independent experiments carried out in duplicates. 
* One-site model was preferred over two-site model by F-test (P<0.05) 
# Fraction (%) of high-affinity binding sites obtained when IC50 values were shared between data 
sets obtained in presence and absence of 10 μM GTPγS 
§: P<0.001 – different from the αH
# value in the absence of GTPγS  
 
As Mn2+ has been shown to elicit tissue specific effects on 5-HT1A signaling, 
which is thought to be connected with coupling of specific Gi protein subtypes 
with these receptors, we decided to additionally study the effects of Mn2+ on 5-
HT binding to the four baculovirus preparations expressing various α-subunits 
in order to see whether the effect is connected with some particular α-subtype. 
The effects of Mn2+ on high affinity Bodipy-FL-NAN-190 binding were 
significant. There was an increase in the proportion of high affinity binding sites 
for all four receptor preparations containing different G-proteins that we 
investigated (Table 3), both in the absence and presence of GTPγS. For 
baculovirus particles not expressing mammalian α-subunits the effect of GTPγS 
on high affinity agonist binding seemed even less pronounced in the presence of 
Mn2+ than in the presence of Mg2+. This result indicates that 5-HT1A receptors 
are more sensitive to Mn2+ effects in the presence of αi-subunits, but these 
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Table 3. Influence of GTPγS on the proportion of 5-HT high affinity binding sites in 




Mg2+ Mn2+ Mg2++GTPγS Mn2++GTPγS
i1 53±2 62±2*** 32±3 40±2* 
i2 36±3 50±2** 19±3 30±3*** 
i3 50±2 60±2*** 28±2 40±2*** 
control 19±2 25±2* 15±2 24±2* 
# Fraction (%) of high-affinity binding sites were calculated from displacement curves of 5-HT 
against 1.35 nM Bodipy-FL-NAN-190. Control experiments were carried out in the absence of 
coexpressed human α-subunits). Data were fitted to a two-site binding model, where high and low 
affinity pIC50 values were shared between all data sets and had values 7.78±0.03 and 6.11±0.02, 
respectively. Data are mean ± SD of pooled data of 2 independent experiments carried out in 
duplicates. 
*: P<0.05, **: P<0.01, ***: P<0.001 – different from the αH
# value in the presence of Mg2+.  
 
 
5.2.2. The effects of nucleotides on high affinity  
Bodipy-FL-NAN-190 binding to 5-HT1A receptors 
As guanine nucleotides clearly altered the ability of agonists to displace 
Bodipy-FL-NAN-190 from 5-HT1A receptors, we used this nucleotide-
dependent effect on high affinity Bodipy-FL-NAN-190 binding for the 
characterization of functional complexes between 5-HT1A receptors and 
different G-proteins. We determined the apparent pEC50 values for GDP and 
GTPγS (in the presence of Mg2+ or Mn2+) to modulate Bodipy-FL-NAN-190 
binding in four different baculovirus preparations, expressing either αi-proteins 
or no mammalian α-subunits. Nucleotide free G-proteins have been shown to be 
essential for high affinity agonist binding (Rinken et al., 2001, Yao et al., 2009), 
so the addition of GDP would be expected to switch the receptor into a low 
affinity binding state, while GTPγS would be expected to functionally sequester 
the G-protein α-subunit from the signaling complex as activation by the 
nonhydrolyzable nucleotide would limit receptor- α-subunit interactions. Thus 
we could study the effect of Mn2+ on both GDP-saturated ternary complexes 
and on signaling complexes where there should be no αi-subunits present 
(nucleotide binding to α-subunits is also affected by Mn2+). For all four 
baculovirus preparations studied we found that the fluorescence anisotropy of 
Bodipy-FL-NAN-190 was higher in the presence of Mn2+ than Mg2+, especially 
in the absence of added nucleotides, while the fluorescence anisotropy of the 
free ligand itself seemed unaffected by Mn2+.  
effects could not be clearly separated in this system due to a background of 
insect G-proteins that also seemed to interact with the receptor.  
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The pEC50 values with which GDP and GTPγS modulated Bodipy-FL-NAN-
190 binding showed that insect G-proteins, when coupled to 5-HT1A receptors, 
have a higher apparent affinity for GTPγS than αi-proteins and lower apparent 
affinity for GDP (Table 4). We found no significant differences between the 
pEC50 values for GTPγS in the presence of either Mg
2+ or Mn2+ for all four 
baculovirus preparations (containing either human or just insect α-subunits) 
studied. This is consistent with the theory that GTPγS uncouples the receptor 
from the G-protein and therefore the effects that divalent cations may have on 
the G-protein α-subunits cannot be detected at the receptor level. However there 
were clear differences between Mg2+ and Mn2+ on effects of GDP, as Mn2+ 
significantly lowered apparent pEC50 values of GDP for all baculovirus 
preparations studied. Similar results were obtained also in our previous 
experiments using [35S]GTPγS to investigate 5-HT1A receptors in rat brain 
membrane homogenates. These findings suggests that Mn2+ may accelerate 
GDP release from the ternary complex, which would lead to increased high 
affinity Bodipy-FL-NAN-190 binding by increasing the proportion of 
nucleotide free G-proteins, which seems to be connected with the higher 
fluorescence anisotropy signals of Bodipy-FL-NAN-190 in the absence of 
added nucleotides. The overall results also indicate that Bodipy-FL-NAN-190 is 
a fluorescent ligand that is well suited for investigating 5-HT1A receptors and 
also their complexes with G-proteins, since as a partial agonist it is sensitive to 
the presence of nucleotide-free G-proteins.  
 
Table 4. Apparent pEC50 values of nucleotides in the presence of 1 mM Mg
2+ or Mn2+ 
to inhibit high affinity agonist binding to 5-HT1A receptors in baculoviruses with 
different human G-protein α-subunits 
Gα 
GDP GTPγS 
Mg2+ Mn2+ Mg2+ Mn2+ 
i1 6.2±0.1 5.7±0.1** 8.6±0.1 8.4±0.1
i2 8.1±0.3 6.3±0.2*** 8.4±0.2 9.0±0.1
i3 6.7±0.1 5.5±0.2*** 8.7±0.2 8.9±0.1
control 5.7±0.2 4.3±0.2* 10±0.5 9.6±0.3
pEC50 values were calculated from concentration-effect curves, where nucleotides modulated 
binding of 1.35 nM Bodipy-FL-NAN-190 to corresponding baculovirus preparations (2.33 nM 5-
HT1A). Control experiments were carried out in the absence of coexpressed human α-subunits). 
Data are mean ± SD of pooled data of 2 or 4 independent experiments carried out in duplicates.  








5.3. Methods for characterization of nucleotide  
binding to purified G-proteins  
In previous experiments receptor-G-protein coupling was investigated in a 
relatively natural environment: measurements were conducted with the proteins 
localized to the plasma membrane (in either cell membrane homogenates or 
budded viruses). In those cases the samples contained numerous proteins that 
could have participated in receptor-G-protein interactions and thus unam-
biguous conclusions about the specific roles of receptor-coupled G-proteins 
were difficult to reach. Therefore a study of the properties of purified G-
proteins was also undertaken, where opportunities for crosstalk are significantly 
reduced and the possibility could be discounted that the receptor could 
contribute selectively to bivalent cation sensitivity or nucleotide-binding 
properties of various αi-subunits. For the following experiments G-protein 
heterotrimers were expressed in Sf9 cell membranes, which were then 
solubilized and purified using affinity chromatography to yield protein 
preparations of over 90% homogeneity. The tandem affinity chromatography 
approach, based on StrepII-tagged γ2-subunits, also enabled partial depletion 
(approximately 0.6 mol of GDP per 1 mol of G-protein was retained) of the 
heterotrimers of endogenous GDP.  
 
5.3.1 Characterization of G-proteins using Bodipy-FL-GTPγS 
Bodipy-FL-GTPγS has been proposed as a promising reporter for 
characterization of nucleotide binding to heterotrimeric G-proteins (McEwen et 
al., 2001). Our results showed that addition of purified heterotrimeric G-
proteins to Bodipy-FL-GTPγS indeed caused increases in both fluorescence 
intensity and fluorescence anisotropy while the baseline fluorescence anisotropy 
of free Bodipy-FL-GTPγS was stable. Upon addition of purified GDP-depleted 
G-proteins, a rapid (τ1/2 < 1 min) increase in anisotropy was detected, which was 
followed by a slower (τ1/2 ~ 10–20 min) decline. The latter process followed, at 
least within the first hour, the kinetics of a first order reaction and so is probably 
connected with thermal inactivation of nucleotide-free G-proteins (Ferguson et 
al., 1986). Indeed, incubation of the protein preparations for an hour at 28 °C 
before addition of Bodipy-FL-GTPγS also caused a significant loss in signal 
intensity. The large transient peaks disappeared and the maximum signals reached 
only ~20–30% of their previous values. The binding of Bodipy-FL-GTPγS was 
also slower, having properties characteristic of GDP-release limited association 
(Senogales et al., 1990, Carty et al., 1990). Similarly, when the nucleotide-
depleted G-proteins were preincubated with GDP, the initial transient peak in 
binding was depressed and a more stable but lower signal was detected. 
Rapid association rates of [35S]GTPγS have previously been detected only for 
nucleotide-free G-protein preparations (Ferguson et al., 1986), while in membrane 
preparations the half-life of this reaction is approximately one hour (Rinken et al., 
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1999). It could therefore be proposed that the initial large pool of easily 
available but unstable binding sites corresponds to a nucleotide-free fraction of 
the purified protein. As the G-proteins used were at least 40 % nucleotide-free, 
they could indeed become partially inactivated during the experiments. 
 
5.3.2. Modulation of nucleotide binding by Mn2+,  
mastoparan and 5-HT1A receptors 
When Mg2+ was replaced with Mn2+ in experiments using GDP-depleted αi-
subunits, this resulted in overall lower transient peaks and also lower stable 
binding levels. However, some G-protein subtype-specific effects were also 
revealed. When comparing the apparent thermal denaturation kinetics of G-
proteins, we observed that Mn2+ decelerated the loss of Bodipy-FL-GTPγS 
binding to αi1, but accelerated it for αi2 (Table 5). In displacement experiments, 
where proteins were preincubated with different concentrations GDP or GTPγS, 
the apparent potencies of these nucleotides to inhibit Bodipy-FL-GTPγS 
binding were decreased up to one order of magnitude by Mn2+ (Table 6) in 
comparison with Mg2+. This effect was most pronounced for GDP binding to 
the αi1- and αi2-subunits (Table 6). In the presence of mastoparan (a receptor 
mimetic) the apparent nucleotide affinities decreased, but the differences in 
pIC50 values achieved a statistically significant level only for the αi2 subunit. 
Mastoparan also significantly accelerated the apparent denaturation rate of αi2 
and the effects were additive with the effects of Mn2+ for this subunit. In 
contrast to other subtypes, Mn2+ had no significant influence on Bodipy-FL-
GTPγS binding to αi3.  
 
Table 5. Rate constants for GDP-depleted G-protein – Bodipy-FL-GTPγS complex 
decompositions 
 kI (min
–1) ± SDa 
αi1 αi2 αi3 
Mg2+ Mn2+ Mg2+ Mn2+ Mg2+ Mn2+ 
–lipob 0.070±0.004 0.059±0.002** 0.043±0.002 0.055±0.002*** 0.052±0.002 0.061±0.006 
+ lipob 0.071±0.007 0.057±0.003* 0.046±0.004 0.052±0.002 0.051±0.006 0.057±0.003 
+lipo  
+ mastb 0.064±0.007 0.058±0.003 0.043±0.006 0.071±0.003***### 0.059±0.005 0.065±0.004 
a first order rate constants (mean ± SD) measured from 12 to 70 minutes after addition of the G-
protein preparation to Bodipy-FL-GTPγS 
b inactivation was measured in the presence (+lipo) or absence (-lipo) of liposomes (14 μg/ml) or 
in the presence of liposomes and mastoparan (10 μM) (+lipo + mast) 
* P<0.05, ** P<0.01, *** P<0.001 vs. corresponding value in the presence Mg2+ 
### P<0.001 vs. corresponding value without mastoparan 
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The apparent opposing effects of Mn2+ on nucleotide-depleted and nucleotide-
saturated purified G-protein preparations indicate that in fact Mn2+ enhances 
nucleotide release from the proteins in both cases. Mn2+ makes nucleotide-
saturated G-proteins initially more available to Bodipy-FL-GTPγS by 
accelerating nucleotide exchange, so GDP can be replaced by the fluorescent 
nucleotide. Mn2+ also makes nucleotide-saturated G-protein preparations less 
stable, which could indicate that G-proteins spend more time in the apparently 
unstable nucleotide free state (which would promote high affinity agonist 
binding). Indeed – in experiments where the reaction medium did not contain 
enough nucleotides to saturate the G-proteins, Mn2+ also inhibited Bodipy-FL-
GTPγS binding in comparison to Mg2+. Taken together, the experiments done in 
the presence of either Mg2+ or Mn2+ seem to indicate that the latter shifts the G-
protein-nucleotide binding equilibrium in favor of the nucleotide free state of 
the α-subunit, rather than either the GDP- or the GTPγS-bound states, which 
seem more stable in the presence of Mg2+.  
 
Table 6. Apparent affinities of GDP and GTPγS to purified protein preparations 
 pIC50
a
 αi1 αi2 αi3 
 Mg2+ Mn2+ Mg2+ Mn2+ Mg2+ Mn2+ 
 GDP 
–lipob 8.12±0.12 7.72±0.11* 8.18±0.07 7.63±0.13*** 8.00±0.07 7.68±0.16* 
+ lipob 8.49±0.20 7.73±0.19* 8.42±0.18 7.84±0.17* 8.05±0.06 7.32±0.20** 
+lipo  
+ mastb 8.57±0.14 7.37±0.21*** 8.26±0.36 7.24±0.35 7.98±0.09 7.71±0.14 
 GTPγS 
+ lipob 8.16±0.06 7.71±0.16** 8.43±0.09 7.85±0.16** 7.92±0.10 7.72±0.22 
+lipo  
+ mastb 7.96±0.10 7.80±0.21 8.13±0.12# 7.90±0.25 7.67±0.14 7.42±0.26 
a negative logarithm of concentration of the nucleotide causing 50 % of inhibition of 5 nM 
Bodipy-FL-GTPγS binding (mean ± SD) measured after 60 minutes incubation 
b the affinities were measured in the presence (+lipo) or absence (-lipo) of liposomes (14 μg/ml) 
or in the presence of liposomes and mastoparan (10 μM) (+lipo + mast) 
* P<0.05, ** P<0.01, *** P<0.001 vs. corresponding value in the presence Mg2+ 
# P<0.05 vs. corresponding value without mastoparan 
 
Comparison of the effects of nucleotides on purified G-proteins and G-proteins 
coexpressed with 5-HT1A receptors in baculovirus particles showed that GDP 
had an effect at much higher concentrations in receptor-coupled G-proteins, 
which indicates functional coupling of G-proteins and 5-HT1A receptors in the 
baculovirus preparations. Also – as Mn2+ had the largest effect on GDP binding 
in both baculovirus preparation expressing αi2 subunits and on the purified αi2 
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subunits themselves – it could be proposed that the effects of Mn2+ on high 
affinity agonist binding in the hippocampus could be the result of enhanced 
coupling of 5-HT1A receptors to αi2 subunits that have been depleted of GDP by 
Mn2+. 
 
5.4. Fluorescent labeling of G-proteins  
for characterization of nucleotide binding 
In addition to measuring fluorescent nucleotide binding to purified proteins, it 
would also be advantageous to be able to use fluorescent approaches for direct 
measurements of nucleotide binding to G-proteins in living cells or membrane 
homogenates. However, no good fluorescent nucleotides have been available 
for monitoring G-protein activation in such environments (Gille and Seifert 
2003) and instead measurement of G-protein heterotrimer association and 
dissociation using FRET-based approaches have more commonly been 
employed (Adjobo-Hermans et al., 2011, Frank et al., 2005). Therefore an 
attempt was made to design new fluorescently-labeled G-proteins for measure-
ments in more natural environments (mammalian cells) and – in addition to the 
abovementioned StrepII and CCKACC tagged γ2-subunits – three CCPGCC-
tagged α-subunits (i2, slong, q) were engineered to enable dual orthogonal 
labeling with biarsenical fluorophores like FlAsH and ReAsH (Chen et al., 
2007). Initial experiments with these putative FRET constructs (using purified 
heterotrimers) however yielded unexpected results: even when the FRET pair 
was labeled with a single biarsenical fluorophore a clear nucleotide-dependent 
signal emerged.  Further experiments were conducted to investigate this effect 
and to see if it could be developed as a novel assay for measuring nucleotide 
binding to G-proteins, beginning with the characterization of some of the 
photophysical changes that accompany F2FlAsH binding to G-proteins.  
Fluorometric measurements showed that the fluorescence intensity of 
F2FlAsH was increased up to twofold by the addition of G-protein α-subunits, 
with no significant shift in emission or absorbance maxima in comparison to 
free F2FlAsH. Measurement of the fluorescence lifetime of F2FlAsH complexes 
(Table 7) showed that free F2FlAsH exhibited a two component exponential 
decay rate with a shorter component of 1.0 ns and a longer component of 4.3 ns, 
with the shorter lifetime component comprising 34% of the signal. Addition of a 
tetracysteine labeled peptide decreased the proportion of the faster decaying 
component down to 11%, as did the addition of βγM, which decreased the 1.0 
ns component down to 25% of the total. When αolf subunits were added to 
F2FlAsH the proportion of the faster decaying component was decreased to 12% 
in the absence of GTPγS, but when the nucleotide was present we observed a 
fluorescence decay rate that was best described by a 3-component fit with a 
previously undetected very rapidly decaying component (τ<0.1 ns, 17% of the 
signal), while the proportion of the 1.0 ns component was increased to 31%.  
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These results indicate that the nucleotide-dependent changes in fluorescence 
anisotropy, which will be described in the following paragraphs, could be the 
result of quenching of F2FlAsH by guanine nucleotides that bind to G-protein α-
subunits in close proximity to the fluorophore. This quenching would (by 
decreasing the time available for rotation) increase fluorescence anisotropy. 
However, if the reaction is accompanied by a change in the rotational 
correlation time (as a result of altered binding or conformational changes) it 
would have the opposite effect on steady state fluorescence anisotropy 
measurements. Thus, the final results would depend on the extent of changes in 
fluorescence lifetime in comparison to changes in the rotational correlation 
time. 
 





F2FlAsH 34±3 1.9 
F2FlAsH+GTPγS 29±1 3.7 
CCPGCC-peptide 11±2 3.8 
βγM 25±2 4.6 
αolf 12±5 1.67
αolf+GTPγS 56±4b 12b 
α13 37±4 6.7 
α13+GTPγS 38±3 2.5 
aFluorescence lifetimes were fitted to equations (1–3) with two components (1.0 ± 0.2 ns and 4.3 
± 0.1 ns) and fractions corresponding to 1.0 ns are reported as mean ± SD 
bA better fit was obtained by including a third very fast component corresponding to 17% of 
fluorescence, but with a lifetime that was below the measurement range of the instrument 
(τ < 0.1 ns) 
 
5.4.1. The effects of nucleotides on the fluorescence anisotropy  
of F2FlAsH complexes with various G-protein sybtypes  
Investigations into the kinetics and nucleotide-dependence of F2FlAsH binding 
to various G-protein subunits showed that addition of purified α-subunits to 
F2FlAsH (in the presence of βγM-subunits) caused an increase in fluorescence 
anisotropy. The magnitude of these increases depended on the α-subunit 
subtype and it could be attenuated by the addition of GTPγS for all 8 α-subunits 
(αi1, αi2, αi3, αslong, αsshort, αolf, αq, α13) studied.  
When F2FlAsH was added to purified wild type α-subunits in the absence of 
tetracysteine-tagged βγM subunits, a large GTPγS-sensitive signal was also 
evident and this time-dependent increase in nucleotide-sensitive fluorescence 
anisotropy was practically unaltered by the presence of βγM-subunits. These 
results indicate that F2FlAsH interacts directly with G-protein α-subunits and 
39 
nucleotide-dependent changes in anisotropy are not the results of α-subunit 
binding to F2FlAsH-labeled βγM subunits in a way that alters the latter’s 
fluorescent properties. In the case of βγM complexes with αsshort, αslong and αolf, 
addition of GTPγS depressed the fluorescence anisotropy signal close to 
F2FlAsH-labeled βγM-levels, which could be interpreted (based of fluorescence 
lifetime measurements) as possible quenching of the fluorophore by the guanine 
nucleotide in close-proximity to the binding site of F2FlAsH, or possibly also by 
some conformational rearrangements of the G-protein heterotrimers (or just α-
subunits) that made the F2FlAsH-binding sites on α-subunits less favorable for 
F2FlAsH interactions upon nucleotide binding. These conformational 
rearrangements may have even led to complete loss of binding for some α-
subunits, although the appearance of a sub 0.1 ns fluorescence lifetime 
component (Table 7) in the presence of GTPγS would not be explained by this. 
Additionally: as G-protein α-subunits may aggregate under certain conditions 
(Agnati et al., 2010), it is possible that nucleotide-dependent changes may have 
been caused by dissociation of α-subunit oligomers (GTPγS is thought to 
disaggregate α-subunits). These oligomers could have presented multiple 
cysteine residues to F2FlAsH in close proximity (in the absence of added 
nucleotides), so F2FlAsH could have cross-linked these α-subunits (leading to 
large increases in fluorescence anisotropy).  
In contrast to αsshort, αslong and αolf the fluorescence anisotropy remained 
higher (in comparison to free F2FlAsH or F2FlAsH-βγM) for αq and α13 in the 
presence of GTPγS. This seems to indicate that F2FlAsH was still able to 
associate with αq and α13 in their nucleotide-bound states – but as this 
interaction with F2FlAsH had limited nucleotide sensitivity, the F2FlAsH-
binding site on these subunits is probably not close enough or oriented properly 
for quenching (or other mechanisms that lower fluorescence anisotropy such as 
disaggregation or conformational rearrangements) by guanine nucleotides. 
Additionally: low nucleotide sensitivity could also be caused by slower 
nucleotide binding to αq and α13.  
 
5.4.2. As-cysteine interactions as a possible  
mechanism for F2FlAsH binding to G-proteins  
F2FlAsH could interact with G-protein α-subunits through either nonspecific 
hydrophobic interactions or through more specific binding modes such as As-
thiol interactions. Our results support the latter and indicate that G-protein α-
subunits compete with high affinity for F2FlAsH binding with other cysteine-
rich proteins or dithiol motifs present in the reaction medium. For example, the 
presence of 2 mM β-mercaptoethanol in the assay buffer (in comparison to 
experiments done in the presence of 5 μM β-mercaptoethanol) had only a small 
effect on nucleotide-sensitive changes in fluorescence anisotropy. Dithiols 
(200µM ethanedithiol) could, however, block the interaction of F2FlAsH with 
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G-protein α-subunits. These results seem to indicate that F2FlAsH binds to 
multiple closely located cysteine residues on G-protein α-subunits. As no such 
residues are present in the highly conserved guanine nucleotide binding site of 
G-proteins (Cabrera-Vera et al., 2010), it appears that F2FlAsH acts as an 
allosteric sensor of nucleotide binding. Unfortunately we were not able to 
directly determine the affinity of F2FlAsH for G-protein α-subunits as a non-
fluorescent biarsenical ligand was not available to us for measuring nonspecific 
F2FlAsH binding. 
We also tested whether nonfluorinated FlAsH (Lumio Green) would 
associate in a nucleotide-sensitive manner with G-protein α-subunits. These 
results were comparable to experiments done using F2FlAsH, indicating that the 
formation of nucleotide-sensitive complexes with G-protein α-subunits is not a 
unique property of F2FlAsH but a more general interaction with biarsenical 
ligands. We also tested whether fluorescein could associate with G-proteins in a 
nucleotide-dependent manner (presumably through hydrophobic interactions): 
no changes in fluorescence anisotropy caused by the addition of G-proteins 
could be detected; neither could we detect any nucleotide effects. This further 
supports the hypothesis that FlAsH analogues bind to cysteine residues on α-
subunits via high affinity As-thiol interactions. 
 
5.4.3. F2FlAsH labeled G-proteins as an assay  
for measuring nucleotide binding  
As guanine nucleotides had robust effects on the fluorescence anisotropy of 
F2FlAsH-αβγM complexes we utilized this system as a novel assay for the 
characterization of nucleotide binding to G-proteins. We note that due to slow 
nucleotide-exchange kinetics and low nucleotide-affinities of some α-subunits, 
traditional orthosteric ligands (labeled nucleotides) would have been limited in 
their applicability, whereas F2FlAsH – as an allosteric probe – could be used to 
monitor their nucleotide-bound states without being as limited by the nucleotide 
exchange requirement. 
Eight different α-subunits in combination with F2FlAsH and βγM were 
studied to reveal the effects of GDP, GMP, GTPγS and GppNHp on these 
complexes. Depending on the α-subunit, large differences in signal amplitudes, 
nucleotide affinities and even in the type of the effect (increase or decrease of 
fluorescence anisotropy) upon addition of guanine nucleotides, was seen. The 
four nucleotides tested had a similar order in their apparent binding affinities for 
all of the G-proteins studied, with GTPγS having the highest and GMP the 
lowest affinity (Table 8). GDP was equipotent with GTPγS and GppNHp for αi-
complexes, but less potent for all other G-protein preparations tested. Similar 
trends were seen for the amplitude of the nucleotide-dependent change in 
fluorescence anisotropy, with GTPγS causing the greatest change, while for 
GDP and GMP the changes were smaller for most α-subunits (with the 
exception of αi2 and αi3). This could indicate that GTPγS binding to α-subunits 
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can cause a conformational rearrangement that brings the quenching guanine 
moiety closer to the F2FlAsH binding site than either GDP or GMP – or 
alternatively: GTPγS leads to disaggregation of α-subunit oligomers while GDP 
and GMP cause smaller conformational rearrangements. 
Proteins of the Gi family differed from the other five G-protein subtypes 
tested in several ways and there were also some specific differences between the 
αi-subunits themselves: these three subunits (purified in nucleotide-depleting 
conditions) exhibited striking differences between the direction of the effects of 
activating guanine nucleotides (nonhydrolyzable GTP-analogues) and GDP or 
GMP (thought to preferentially bind to and stabilize inactive G-protein 
conformations). In comparison to experiments done without added nucleotides, 
the addition of GDP and GMP caused an increase in fluorescence anisotropy, 
whereas the addition of GTPγS and GppNHp resulted in a decrease. This could 
indicate that the nucleotide-depleted αi-subunit preparations partially denatured 
at 28 °C and could no longer interact with F2FlAsH (when no additional GDP or 
GMP was present), whereas the addition of GDP or GMP could stabilize the 
nucleotide-free pool of α-subunits and preserve their F2FlAsH binding ability, 
thus increasing the signal. Alternatively the stabilizing effects of GDP and GMP 
could be connected with the stability of the G-protein heterotrimer itself: GDP-
bound αi-subunits would be expected to be associated with βγM-subunits, 
which would reduce their rotational mobility, while GTPγS treatment would be 
expected to (fully or partially) dissociate the heterotrimer and lead to a decrease 
in fluorescence anisotropy. Disaggregation of αi-subunits themselves by GTPγS 
is also a possible mechanism behind the different effects of activating and 
nonactivating guanine nucleotides as αi-subunits are thought to be especially 
likely to aggregate (Agnati et al., 2010). Additionally, as the affinity of these 
three Gi protein preparations for GDP and GTPγS had been measured 
previously using a Bodipy-FL-GTPγS-based nucleotide displacement assay in a 
similar environment, we could directly compare the results from the two 
methods: the affinity of αiβγM complexes for GDP and GTPγS determined 
using Bodipy-FL-GTPγS was in close agreement with the values obtained by 
using the F2FlAsH-based assay. Also, our estimation of the apparent affinity of 
GTPγS for αs-subunits is similarly close to previously published values 
determined using assays based on the displacement of fluorescent nucleotides 
(McEwen et al., 2001) and high concentrations (10-30 μM) of GTPγS have 
previously been found necessary to activate αq and α13 (Chan et al., 2011), 
which is reflected by our results: these two proteins had the lowest apparent 
affinity for GTPγS out of all the G-protein subtypes studied.  
There may be several reasons why the effects GDP and GMP had on αi-
subunits differed from other G-protein subtypes. One reason may be that αsshort, 
αslong, αq, αolf and α13-proteins were not purified in nucleotide-depleting 
conditions, so they could have been saturated with GDP. These 5 α-subunits had 
all been purified using GST-Ric8 association (Chan et al., 2011) instead of 
StrepII-labeled γ2-subunits, as was the case for αi-heterotrimers. So these two 
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purification approaches may have yielded protein preparations that had 
significantly different compositions in terms of nucleotide and cofactor content 
and also in G-protein subunit stoichiometry.  
 
Table 8. Apparent affinities of nucleotides in F2FlAsH-αβγM complexes 
 pEC50
a
 GTPγS GppNHp GDP GMP 
αslong 7.47 ± 0.09 6.56 ± 0.07 4.72 ± 0.18 ND 
αsshort 7.06 ± 0.04 6.42 ± 0.04 4.85 ± 0.05 >–3 
α13 5.65 ± 0.13 5.36 ± 0.14 4.98 ± 0.23 ND 
αq 6.27 ± 0.05 5.96 ± 0.07 5.87 ± 0.06 >–3 
αolf 6.43 ± 0.04 5.84 ± 0.05 5.00 ± 0.03 >–3 
αi1 8.19 ± 0.05 8.08 ± 0.04 8.19 ± 0.16 5.89 ± 0.12
αi2 8.02 ± 0.09 7.84 ± 0.14 8.17 ± 0.13 4.45 ± 0.07
αi3 7.87 ± 0.06 7.93 ± 0.07 8.08 ± 0.10 5.29 ± 0.13
a negative logarithm of concentration of the nucleotide causing 50 % of fluorescence anisotropy 
changes of F2FlAsH-αβγM complexes (mean ± SD), determined after 6 h incubation for αslong, 
αsshort, αq and αolf, after 14 h for α13, after 2 h for αi1, αi2 and αi3. 
Data is from two to three independent experiments carried out in duplicate. Data were pooled and 
then fitted to three parameter competitive binding equations.  
 
When comparing the effects of nucleotides on F2FlAsH-G-protein complexes, it 
was apparent that F2FlAsH-αiβγM protein complexes had the highest 
fluorescence anisotropy in the presence of GDP or GMP, while the same was 
true for F2FlAsH-αsshort, αslong, αq, αolf and α13 complexes in the absence of any 
added nucleotides. It has been suggested that αi-subunits in their GDP-bound 
state could have multiple binding sites for βγ-subunits (Wang et al., 2009), 
which could also (in addition to inhibition of denaturation of nucleotide-free αi-
subunits) explain the increase in fluorescence anisotropy upon GDP and GMP 
binding to αi-subunits: βγM subunits were probably present at a slight excess in 
the αiβγM protein preparations, so they could form complexes with at least 
some αiβγM-heterotrimers. The added mass of a second βγM binding to the G-
protein heterotrimer would be expected to further decrease the rotational 
mobility of the F2FlAsH-G-protein complex and result in a slightly higher 
anisotropy. Thus absence of any GDP or GMP-induced increase in the 
fluorescence anisotropy of αsshort, αslong, αq, αolf and α13 complexes with 
F2FlAsH and βγM could be explained by the lack of a second βγM-subunit 





In summary our studies into the role of G-proteins in the regulation of 5-HT1A 
mediated signal transduction led to the following conclusions: 
 5-HT1A receptor signaling complexes in the rat brain are differentially 
regulated by Mn2+, which caused an increase of high-affinity agonist binding 
in rat hippocampal membranes in comparison with experiments in the 
presence of Mg2+, but not in rat cortical membranes or Sf9 cell membranes 
expressing 5-HT1A receptors and Gi1 heterotrimers.  
 Activation of G-proteins with 30 µM GTPγS turned all 5-HT1A receptors in 
the above-mentioned tissue preparations into a low-affinity state for agonist 
binding in the presence of Mg2+, but not in the presence of Mn2+ in rat 
hippocampal membranes. However, at 1 µM GTPγS, a substantial amount of 
high affinity agonist binding in the presence of Mn2+ was detected also in 
cortical membranes and Sf9 cells, but not with Mg2+.  
 Comparison of the abilities of GDP and GTPγS to modulate high affinity 
agonist binding to 5-HT1A receptors indicated that both nucleotides were 
almost 10-fold less potent in the presence of Mn2+ in comparison to Mg2+. 
This means that by inhibiting guanosine nucleotide binding to G-proteins in 
complex with 5-HT1A receptors, Mn
2+ acts as an enhancer for agonist 
binding.  
 Bodipy-FL-NAN-190 was found to be well suited reporter ligand for 
characterization of ligand binding to 5-HT1A receptors expressed in budded 
baculovirus particles, as binding is accompanied by large increases in 
fluorescence intensity and anisotropy.  
 The fluorescence anisotropy assay based on Bodipy-FL-NAN-190 binding to 
baculovirus particles was suitable for the characterization of binding 
properties of non-labeled serotonergic ligands, but also for characterizing the 
abilities of different G proteins to promote high affinity agonist binding. 
There were no significant differences between αi1 and αi3 subtypes, while 
ligand binding in the presence of αi2 had higher sensitivity to GDP and 
Mn2+.  
 StrepII-tagged γ2-subunits were an expedient construct for the purification of 
heterotrimeric G-proteins and also for depleting them of bound nucleotides. 
Nucleotide depletion greatly accelerated the denaturation rates of αi-
subunits.  
 Fluorescence anisotropy measurements with Bodipy-FL-GTPγS enabled on-
line monitoring of the binding of this ligand and revealed differences in the 
sensitivities of nucleotide-depleted and saturated Gαi-proteins to Mn2+– and 
mastoparan: in comparison to Mg2+, Mn2+ inhibited nucleotide binding to all 
αi-heterotrimers studied and accelerated nucleotide release. Mn2+ had 
stabilizing effect on the nucleotide free state of the αi1 subunit, whereas both 
Mn2+ as well as activation by mastoparan destabilized the αi2 subunit.  
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 The biarsenic fluorescent ligand F2FlAsH binds to various wild-type G-
protein α-subunits (αi1, αi2, αi3, αslong, αsshort, αolf, αq, α13) via high affinity 
As-cysteine interactions. This allosteric probe enables on-line monitoring of 
the nucleotide bound states of α-subunits via changes in fluorescence 
anisotropy and intensity of their F2FlAsH-complexes.  
 Addition of nucleotides to F2FlAsH-labeled α-subunits caused con-
centration-dependent effects on their fluorescence anisotropy. Nucleotide 
affinities for GTPγS, GppNHp, GDP and GMP were comparable to values 
obtained in assays based on the displacement of labeled nucleotides.  
 GDP and GMP seemed to stabilize nucleotide-depleted F2FlAsH-αi-subunit 
complexes, whereas for all other α-subunits tested the fluorescence 
anisotropy decreased in their presence. GTPγS and GppNHp decreased 
fluorescence anisotropy for F2FlAsH-α-subunit complexes for all G-protein 
subtypes studied.  
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7. SUMMARY IN ESTONIAN 
G-valkude alatüüpide regulatsioon retseptorite, 
guaniinnukleotiidide ja Mn2+ poolt 
Käesoleva töö eesmärgiks oli uurida signaaliülekande mehhanisme, mida 
vahendavad G-valk seotud retseptorid: valgud, mille kaasabil aktiveerivad raku 
väljaspoolt tulevad (sageli keemilised) signaalid raku sisemuses olevaid hetero-
trimeerseid guaniinnukleotiide siduvaid valke (G-valke). G-valk seotud retsep-
torid kuuluvad inimese suurimasse (erinevatel hinnangutel kuni 800 liikmega) 
integraalsete membraanvalkude perekonda ning nad osalevad väga palju-
des füsioloogilistes protsessides (olles seega olulisteks ravimimärklaudadeks): 
alustades embrüonaalsete rakkude diferentseerumisest kuni kesknärvisüsteemi 
täppisregulatsioonini välja. Nende poolt aktiveeritavaid G-valkude perekonda 
kuulub samas vaid paarkümmend liiget, mis samuti interakteeruvad võrdlemisi 
tagasihoidliku hulga rakusiseste efektoritega.  
Serotoniin 1A retseptor (5-HT1AR) kuulub G-valk seotud retseptorite pere-
konda ning omab mitmeid rolle kesknärvisüsteemis nagu meeleolu, une ja 
seksuaalkäitumise regulatsioon. Samuti on välja pakutud hüpotees, et see ret-
septor võib omada rolli mangaani mürgistuse korral tekkivate sümptomite välja-
kujunemisel: biokeemilised mõõtmised on näidanud, et mangaan omab teatud 
ajupiirkondades märgatavat mõju agonistide retseptoriga seostumisele. See 
piirkonna-spetsiifiline regulatsioon näib olevat seotud vastavates kudedes 
leiduvate G-valkude mangaani poolt mõjutatavate nukleotiidide seostumise 
mehhanismidega. Nende mehhanismide väljaselgitamine ning selleks vajalike 
uudsete mõõtmismeetodite välja töötamine oligi antud töö kitsamaks ees-
märgiks. 
Esmased mõõtmised rakendasid klassikalisi radioaktiivselt märgistatud 
ligandidel põhinevaid meetodeid, et uurida 5-HT1AR-it tema võrdlemisi loomu-
likus keskonnas: imetaja kesknärvisüsteemi koepreparaatides. Lisaks võrdle-
sime ajukudedes saadud tulemusi mõõtmistega, kus rakendati heteroloogselt 
putukarakkudes ekspresseeritud retseptoreid. Tulemused näitasid, et sõltuvalt 
aktiveerivate nukleotiidide kontsentratsioonist omas mangaan mõju kõrge 
afiinsusega agonisti sidumisele kas ainult roti hipokampuses või lisaks ka teistes 
koepreparaatides – kui G-valkude aktivatsiooniks kasutati madalat nukleotiidi 
kontsentratsiooni. Samuti omas mangaan suurt mõju nukleotiidide võimele 
moduleerida kõrge afiinsusega agonisti seostumist, vähendades näivaid 
nukleotiidide afiinsust ligi 10 kordselt.  
Edasised mõõtmised kasutasid samuti putukarakkudest pärit retseptoreid 
kuid mõõtmised teostati uudse fluorestsentsligandiga: Bodipy-FL-NAN-190-
iga. Esmalt iseloomustasime selle ligandi omadusi, et veenduda tema sobivuses 
5-HT1AR-i uurimiseks. Samuti kasutasime 5-HT1AR-allikana bakuloviirus-
osakesi, mis võimaldasid mõõtmisi reaalajas rakendades fluorestsentsaniso-
troopia meetodit. Ekspresseerides viirusosakestes koos retseptoriga erinevaid 
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Gi-valkude alaühikuid õnnestus mõõta mangaani selektiivset mõju erinevate 
retseptor-G-valk komplekside funktsioneerimisele. Tulemused näitasid, et 
mangaan näis omavat suurimat mõju i2-alaühikule ning et Bodipy-FL-NAN-
190 seostumine bakuloviirustes ekspresseeritud 5-HT1A retseptorile on sobilik 
mudelsüsteem selle retseptori G-valk komplekside iseloomustamiseks. 
Olles eelnevalt uurinud mangaani mõju nukleotiidide G-valkudele seostu-
misele 5-HT1A retseptori juuresolekul teostasime järgmised mõõtmised bio-
keemiliselt oluliselt paremini defineeritud mudelsüsteemiga: kasutades puhas-
tatud G-valke. Nende valkude saamiseks töötasime välja puhastamismetoodika, 
mis ühtlasi võimaldas saada nukleotiidivabasid G-valke. Puhastatud valkudega 
katsed võimaldasid määrata nende alatüüpide vahelisi erinevusi olukorras, kus 
retseptori mõju oli välistatud. Selleks kasutasime fluorestsentsmärgistatud 
nukleotiidide, mille seostumist jälgisime fluorestsentsanisotroopia meetodil. 
Taaskord näitasid tulemused, et mangaani mõju on suurim i2-alaühikule, vähen-
dades nii nukleotiidide afiinsust kui ka selle valgu enda stabiilsust. Samas i3-
alaühikule mangaani märgatav mõju puudus. i1-alaühiku puhul oli väike efekt 
olemas (mangaan vähendas nukleotiidide afiinsust) kuid katiooni mõju valgu 
denaturatsioonile näis olevat vastupidine i2-alaühikuga. Seega võib järeldada, et 
mangaani mõju kõrge afiinsusega agonistide seostumisele 5-HT1AR-iga on 
tihedalt seotud mangaani poolt tekitatud nukleotiidivaba G-valgu sisaldusega 
retseptor-G-valk kompleksis. 
Viimase eesmärgina plaanist uurida G-valkude rolli signaaliülekandes oli 
proovida mõõta G-valkude selektiivset aktivatsiooni imetajarakkudes, mida 
fluorestsentsnukleotiididel põhinevate meetoditega oleks väga komplitseeritud 
(kui mitte võimatu) teha. Selleks disainisime mitmeid fluorestsents-
märgistamist-võimaldavaid G-valke, et mõõta elavates rakkudes nende aktivat-
siooni kasutades Försteri resonantsenergia ülekande printsiipi. Kontrollkatsed 
saadud valkudega aga näitasid, et märgistamiseks kasutatav biarseenne fluoro-
foor seostub samuti ka natiivsete G-valkude α-alaühikutega (kõrge afiinsusega 
arseen-tsüsteiin interaktsioonide kaudu), mis võimaldasid täiesti uudsel viisil 
jälgida nukleotiidide seostumist ning G-valkude aktivatsiooni in vitro. Seda 
isegi G-valkude puhul, millele jälgimine traditsiooniliste ortosteeriliste ligan-
didega on nukleotiidide aeglase dissotsiatsioonikineetika tõttu raskendatud.  
Biarseensete ligandidel põhineva meetodi abil uurisime kaheksat erinevat G-
valgu α-alaühikut. Mõõdetud nukleotiidide afiinsused langesid kokku kirjan-
duse andmetega, mis põhinesid märgistatud nukleotiidide seostumisel. Samuti 
näitasid tulemused, et G-valkude alatüüpide vahel on suuri erinevusi ning Gi 
valgud eristusid selgelt teiste G-valkude perekondade liikmetest kuna nende 
puhul sõltus signaali muutuse suund lisatud nukleotiidi tüübist, samas kui kõigi 
teiste α-alaühikute puhul viis kõikide nukleotiidide lisamine signaali vähene-
miseni (tõenäoliselt fluorestsentsligandi emissiooni kustutamise kaudu). 
Kokkuvõtvalt näitasid meie tulemused, et 5-HT1A retseptori ning tema G-
valk komplekside uurimiseks saab edukalt kasutada mitmeid fluorestsents-
meetodeid, mis võimaldavad mõõtmisi homogeenses keskkonnas ning reaalajas. 
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Kasutades bakuloviirustel põhinevat ekpressioonisüsteemi saab hõlpsalt eks-
presseerides koos retseptoriga erinevaid G-valkude alatüüpe ja uurida alatüüp-
selektiivseid retseptor-G-valk interaktsioone ning nende tundlikkust guaniinnu-
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